WASHINGTON, March 11 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Fareva Morton Grove from its Center for Drug Evaluation and Research:

* * *

Recipient: Mr. Bernard Fraisse, Founder and CEO, Fareva Morton Grove, 1 Avenue President Wilson, 75016 Paris, France

Issuing Office: Center for Drug Evaluation and Research (CDER), United States

Warning Letter 320-26-48